PARIS–(BUSINESS WIRE)–Juvisé Pharmaceuticals acquires multiple sclerosis drug PONVORY® (ex-US/Canada) and opens its capital to Bpifrance and Pemberton
Business Wire Merger/Acquisition News
Enjoying Merger Arbitrage Limited?
Sign up then! It's quick and FREE
Have time to share an article? It's very much appreciated!!